AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 89 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $28,000 | -89.5% | 12,096 | -78.4% | 0.00% | -100.0% |
Q4 2021 | $266,000 | +224.4% | 55,945 | +377.3% | 0.00% | +200.0% |
Q2 2021 | $82,000 | -41.8% | 11,722 | -34.3% | 0.00% | -50.0% |
Q1 2021 | $141,000 | +95.8% | 17,835 | +93.7% | 0.00% | +100.0% |
Q4 2020 | $72,000 | +14.3% | 9,208 | +3.6% | 0.00% | 0.0% |
Q3 2020 | $63,000 | -35.7% | 8,890 | -16.5% | 0.00% | -50.0% |
Q2 2020 | $98,000 | -25.2% | 10,647 | -13.8% | 0.00% | -71.4% |
Q2 2018 | $131,000 | – | 12,346 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 340,679 | $3,604,000 | 1.39% |
Nantahala Capital Management | 2,213,052 | $23,414,000 | 0.95% |
SCP Investment, LP | 156,137 | $1,652,000 | 0.82% |
SPHERA FUNDS MANAGEMENT LTD. | 509,118 | $5,386,000 | 0.74% |
DELTEC ASSET MANAGEMENT LLC | 151,781 | $1,606,000 | 0.32% |
Rock Springs Capital Management LP | 650,000 | $6,877,000 | 0.26% |
Orbimed Advisors | 1,865,524 | $19,737,000 | 0.24% |
Baker Brothers Advisors | 1,387,872 | $14,684,000 | 0.11% |
EAM Investors, LLC | 56,726 | $600,000 | 0.10% |
Stanley-Laman Group, Ltd. | 35,036 | $371,000 | 0.08% |